191 related articles for article (PubMed ID: 38413629)
1. Changes in kynurenine metabolites in the gray and white matter of the dorsolateral prefrontal cortex of individuals affected by schizophrenia.
Antenucci N; D'Errico G; Fazio F; Nicoletti F; Bruno V; Battaglia G
Schizophrenia (Heidelb); 2024 Feb; 10(1):27. PubMed ID: 38413629
[TBL] [Abstract][Full Text] [Related]
2. Altered kynurenine pathway metabolites in serum of chronic migraine patients.
Curto M; Lionetto L; Negro A; Capi M; Fazio F; Giamberardino MA; Simmaco M; Nicoletti F; Martelletti P
J Headache Pain; 2015; 17():47. PubMed ID: 27130315
[TBL] [Abstract][Full Text] [Related]
3. Altered serum levels of kynurenine metabolites in patients affected by cluster headache.
Curto M; Lionetto L; Negro A; Capi M; Perugino F; Fazio F; Giamberardino MA; Simmaco M; Nicoletti F; Martelletti P
J Headache Pain; 2015; 17(1):27. PubMed ID: 27000870
[TBL] [Abstract][Full Text] [Related]
4. Effect of Kynurenic Acid on Pupae Viability of Drosophila melanogaster cinnabar and cardinal Eye Color Mutants with Altered Tryptophan-Kynurenine Metabolism.
Navrotskaya V; Wnorowski A; Turski W; Oxenkrug G
Neurotox Res; 2018 Aug; 34(2):324-331. PubMed ID: 29619629
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of kynurenine pathway and potential dynamic changes of kynurenine in schizophrenia: A systematic review and meta-analysis.
Cao B; Chen Y; Ren Z; Pan Z; McIntyre RS; Wang D
Neurosci Biobehav Rev; 2021 Apr; 123():203-214. PubMed ID: 33513412
[TBL] [Abstract][Full Text] [Related]
6. Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder.
Meier TB; Drevets WC; Wurfel BE; Ford BN; Morris HM; Victor TA; Bodurka J; Teague TK; Dantzer R; Savitz J
Brain Behav Immun; 2016 Mar; 53():39-48. PubMed ID: 26546831
[TBL] [Abstract][Full Text] [Related]
7. Increased breakdown of kynurenine towards its neurotoxic branch in bipolar disorder.
Birner A; Platzer M; Bengesser SA; Dalkner N; Fellendorf FT; Queissner R; Pilz R; Rauch P; Maget A; Hamm C; Herzog-Eberhard S; Mangge H; Fuchs D; Moll N; Zelzer S; Schütze G; Schwarz M; Reininghaus B; Kapfhammer HP; Reininghaus EZ
PLoS One; 2017; 12(2):e0172699. PubMed ID: 28241062
[TBL] [Abstract][Full Text] [Related]
8. Kynurenine pathway metabolites are associated with gray matter volume in subjects with schizophrenia.
Zhou S; Huang Y; Kuang Q; Yan S; Li H; Wu K; Wu F; Huang X
Front Psychiatry; 2022; 13():941479. PubMed ID: 36016974
[TBL] [Abstract][Full Text] [Related]
9. Kynurenic acid and 3-hydroxykynurenine production from D-kynurenine in mice.
Wang XD; Notarangelo FM; Wang JZ; Schwarcz R
Brain Res; 2012 May; 1455():1-9. PubMed ID: 22498176
[TBL] [Abstract][Full Text] [Related]
10. Peripheral kynurenine-3-monooxygenase deficiency as a potential risk factor for metabolic syndrome in schizophrenia patients.
Oxenkrug G; van der Hart M; Roeser J; Summergrad P
Integr Clin Med; 2017; 1(1):. PubMed ID: 28748226
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of kynurenine metabolism is related to proinflammatory cytokines, attention, and prefrontal cortex volume in schizophrenia.
Kindler J; Lim CK; Weickert CS; Boerrigter D; Galletly C; Liu D; Jacobs KR; Balzan R; Bruggemann J; O'Donnell M; Lenroot R; Guillemin GJ; Weickert TW
Mol Psychiatry; 2020 Nov; 25(11):2860-2872. PubMed ID: 30940904
[TBL] [Abstract][Full Text] [Related]
12. The kynurenine pathway in major depressive disorder under different disease states: A systematic review and meta-analysis.
Ou W; Chen Y; Ju Y; Ma M; Qin Y; Bi Y; Liao M; Liu B; Liu J; Zhang Y; Li L
J Affect Disord; 2023 Oct; 339():624-632. PubMed ID: 37467793
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of kynurenine pathway metabolism in Toxoplasma gondii-infected mice: implications for schizophrenia.
Notarangelo FM; Wilson EH; Horning KJ; Thomas MA; Harris TH; Fang Q; Hunter CA; Schwarcz R
Schizophr Res; 2014 Jan; 152(1):261-7. PubMed ID: 24345671
[TBL] [Abstract][Full Text] [Related]
14. Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism.
Fukui S; Schwarcz R; Rapoport SI; Takada Y; Smith QR
J Neurochem; 1991 Jun; 56(6):2007-17. PubMed ID: 1827495
[TBL] [Abstract][Full Text] [Related]
15. The association between inflammation and kynurenine pathway metabolites in electroconvulsive therapy for schizophrenia: Implications for clinical efficacy.
Wang Y; Fang X; Wang G; Tang W; Liu S; Yang Y; Chen J; Ling Y; Zhou C; Zhang X; Zhang C; Su KP
Brain Behav Immun; 2023 Oct; 113():1-11. PubMed ID: 37353059
[TBL] [Abstract][Full Text] [Related]
16. Preliminary comparative analysis of kynurenine pathway metabolites in chronic ketamine users, schizophrenic patients, and healthy controls.
Zhang Z; Zhang M; Luo Y; Ni X; Lu H; Wen Y; Fan N
Hum Psychopharmacol; 2020 Jul; 35(4):e2738. PubMed ID: 32352599
[TBL] [Abstract][Full Text] [Related]
17. Deficiency of kynurenine 3-monooxygenase exacerbates impairment of prepulse inhibition induced by phencyclidine.
Kubota H; Kunisawa K; Niijima M; Hirakawa M; Mori Y; Hasegawa M; Fujigaki S; Fujigaki H; Yamamoto Y; Saito K; Nabeshima T; Mouri A
Biochem Biophys Res Commun; 2022 Nov; 629():142-151. PubMed ID: 36116377
[TBL] [Abstract][Full Text] [Related]
18. Dynamic changes in metabolites of the kynurenine pathway in Alzheimer's disease, Parkinson's disease, and Huntington's disease: A systematic Review and meta-analysis.
Fathi M; Vakili K; Yaghoobpoor S; Tavasol A; Jazi K; Hajibeygi R; Shool S; Sodeifian F; Klegeris A; McElhinney A; Tavirani MR; Sayehmiri F
Front Immunol; 2022; 13():997240. PubMed ID: 36263032
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of [5-3H]kynurenine in the rat brain in vivo: evidence for the existence of a functional kynurenine pathway.
Guidetti P; Eastman CL; Schwarcz R
J Neurochem; 1995 Dec; 65(6):2621-32. PubMed ID: 7595559
[TBL] [Abstract][Full Text] [Related]
20. Role of the immune-kynurenine pathway in treatment-resistant schizophrenia.
Chen W; Tian Y; Gou M; Wang L; Tong J; Zhou Y; Feng W; Li Y; Chen S; Liu Y; Wang Z; Pan S; Zhang P; Huang J; Yang X; Li CR; Tian L; Hong LE; Tan Y
Prog Neuropsychopharmacol Biol Psychiatry; 2024 Mar; 130():110926. PubMed ID: 38147973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]